BRCA1 and breast cancer: Previous in vitro experiments using breast cancer cells showed that BRCA1-negative cells were less sensitive to paxlitaxel than BRCA1-positive cells (Tassone et al. 2003), and that BRCA1 might be required for the induction of apoptosis in response to paclitaxel in breast cancer cells (Quinn et al. 2003).